All In Biotech

Free tool

FAERS Monitor: Kenalog-40

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 014901 or its brand name (Kenalog-40, Triamcinolone Acetonide). Reports on generic versions are filed under their own applications.

Reports

26,375

Serious

13,659

52% of reports

Hospitalization

6,462

Death reported

3,186

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,884
  • off label use2,930
  • pruritus2,762
  • rash2,589
  • pain2,199
  • fatigue2,074
  • nausea1,988
  • product use in unapproved indication1,770
  • diarrhoea1,720
  • vomiting1,716
  • headache1,688
  • condition aggravated1,682
  • arthralgia1,578
  • dizziness1,503
  • infusion related reaction1,419

Reports by year received

View as table
YearReports
2004145
2005141
2006181
2007146
2008232
2009191
2010195
2011293
2012206
2013228
2014368
2015600
2016789
2017970
20181,175
20191,313
20201,533
20211,813
20222,342
20232,752
20243,567
20253,888
20263,307

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,784 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal1,41917.416.621,548
pruritusSignal2,7625.85.610,998
product use in unapproved indicationSignal1,7705.75.56,937
rashSignal2,5894.84.67,799
condition aggravatedSignal1,6824.44.24,505
arthralgiaSignal1,5783.02.92,185
vomitingSignal1,7162.92.82,202
painSignal2,1992.92.72,731
off label useSignal2,9302.72.63,191
dizzinessSignal1,5032.42.31,261
drug ineffectiveSignal3,8842.42.33,217
headacheSignal1,6882.22.11,066
diarrhoeaSignal1,7202.12.01,057
fatigueSignal2,0742.12.01,282
nauseaSignal1,9882.01.91,038

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.